全文获取类型
收费全文 | 129篇 |
免费 | 9篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 4篇 |
妇产科学 | 2篇 |
基础医学 | 10篇 |
口腔科学 | 4篇 |
临床医学 | 3篇 |
内科学 | 29篇 |
皮肤病学 | 9篇 |
神经病学 | 6篇 |
特种医学 | 5篇 |
外科学 | 16篇 |
综合类 | 9篇 |
预防医学 | 2篇 |
眼科学 | 6篇 |
药学 | 30篇 |
肿瘤学 | 10篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 4篇 |
2020年 | 2篇 |
2019年 | 12篇 |
2018年 | 7篇 |
2017年 | 2篇 |
2015年 | 3篇 |
2014年 | 2篇 |
2013年 | 9篇 |
2012年 | 2篇 |
2011年 | 2篇 |
2010年 | 4篇 |
2009年 | 2篇 |
2008年 | 5篇 |
2007年 | 2篇 |
2006年 | 1篇 |
2005年 | 5篇 |
2004年 | 3篇 |
2003年 | 1篇 |
2002年 | 3篇 |
2001年 | 3篇 |
2000年 | 5篇 |
1999年 | 3篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 8篇 |
1994年 | 11篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1990年 | 3篇 |
1988年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 7篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 4篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1973年 | 2篇 |
排序方式: 共有145条查询结果,搜索用时 46 毫秒
1.
Demetrius Ellis Ron Shapiro Mark L. Jordan Velma P. Scantlebury Nisan Gilboa Laszlo Hopp Nancy Weichler Andreas G. Tzakis Richard L. Simmons 《Pediatric nephrology (Berlin, Germany)》1994,8(2):193-200
Clinical aspects of FK-506 or cyclosporine immunosuppression regimens were evaluated in 48 consecutive pediatric renal transplant recipients. Tapering and discontinuation of prednisone was employed only in children receiving FK-506 who experienced minor or no rejection episodes during the 1st posttransplant month. At 1 year follow-up, 17 of 22 (77%) of all children with functioning allografts were receiving no prednisone (n=13) or a mean dosage of 0.07 mg/kg per day (n=4). During the 1st month, acute cellular rejection was more common in the FK-506 group (0.58 vs. 0.21 rejections per patient,P<0.05) but allograft survival (92%) and renal function at 1 year posttransplant were identical in both groups. Compared with the cyclosporine regimen, FK-506 immunosuppression may be associated with a higher incidence of cytomegalovirus or reversible Epstein-Barr virus-induced lymphoproliferative disease. However, the FK-506 group had less hirsutism and gingival hypertrophy and required fewer antihypertensive medications independent of steroid use. Height standard deviation scores and weight-for-height index improved only in preadolescents receiving FK-506 but no prednisone (P<0.02 andP<0.05, respectively), but did not differ between children on FK-506 plus prednisone and those in the cyclosporine group. We conclude that the major advantages of FK-506 over cyclosporine immunosuppression are a reduced severity of hypertension and an improved cosmetic appearance which may improve long-term medical compliance. When used as monotherapy, FK-506 also shows promise in relieving the growth retardation associated with cyclosporine regimens that include prednisone. 相似文献
2.
The distribution kinetics of a novel potent immunosuppressant, FK-506 (FK) has been studied in comparison with cyclosporin A (CyA) both in vivo and in vitro using blood specimens. The infusion studies on FK, 5.0 mg kg-1 through the portal and femoral veins showed that the mean hepatic extraction ratio of FK was 27.9 per cent. The effect of clamping both the hepatic artery and the portal vein on the plasma disappearance profiles of FK, 5.0 mg kg-1, and CyA, 3.5 mg kg-1 was studied. The plasma disposition kinetics of CyA was almost the same as in the normal rats. However, the plasma FK levels were about 10 times higher than those obtained in the control group rats. This difference is attributed to the restricted initial distribution of FK to the liver, because the volume of the initial distribution space, V1, of FK was about 10 times smaller than that obtained in normal rats. In in vitro experiments, drug distribution was studied in blood samples (2.0 ml) spiked with FK or CyA, 1.0 micrograms ml-1. The plasma drug levels measured at 2 min after drug administration were 0.842 +/- 0.012 micrograms ml-1 and 0.769 +/- 0.047 micrograms ml-1 for FK and CyA, respectively. The distribution volume in the blood compartment, VB, was determined by dividing the spiked amount of drugs with these plasma concentrations. The VB was 2.38 +/- 0.04 ml for FK and 2.62 +/- 0.16 ml for CyA. There was no significant difference in VB between FK and CyA. The plasma free fraction, fp of the drugs was measured by the equilibrium dialysis method. For FK, the mean fp values (+/- SE) were 1.31 +/- 0.18 per cent (2.0 micrograms ml-1) and 1.93 +/- 0.18 per cent (5.0 micrograms ml-1). For CyA, the fp values were 4.85 +/- 0.36 per cent (1.0 micrograms ml-1) and 5.75 +/- 0.82 per cent (5.0 micrograms ml-1). The hydrophobicity parameter, logP' determined through the HPLC method was 0.386 for FK and 0.545 for CyA. Although FK was less hydrophobic than CyA, its protein binding was higher than CyA. 相似文献
3.
Kanji Takada Naohisa Katayama Akiko Kiriyama Hisato Usuda 《Biopharmaceutics & drug disposition》1993,14(8):659-671
Using two representative immunosuppressants, FK506 (FK) and cyclosporin A (CyA), of which the mechanism of pharmacological action is the same although there is a great difference in the pharmacological intensity, the distribution characteristics were studied in both in vivo and in vitro experiments using rat, dog, and human blood. Blood samples were fractionated by means of sedimentation in Ficoll-Paque®, and the drug contents in the diluted plasma fraction, erythrocyte fraction, and lymphocyte fraction were measured by an HPLC method. FK distributes to the lymphocyte fraction to a level about three times greater than that of CyA, while CyA distributes to the erythrocyte fraction to a level ten times that of FK. The distribution pattern of these fractions was independent of the drug concentration and species after correcting the drug concentration in each fraction with the blood drug concentration. The uptakes of FK and CyA in the isolated lymphocytes obtained from the rat spleen and human peripheral blood were also studied. The amount of FK taken up by the spleen lymphocytes is five times greater than that of CyA. In the case of the uptake study using human peripheral blood lymphocytes, the concentration of FK in the lymphocyte is 100-fold higher than that of CyA. This difference in the lymphocyte level between the two immunosuppressants is thought to be one of the reasons why FK is more potent than CyA, a difference of about 100-fold in the in vitro pharmacological study and about tenfold in the in vivo organ transplantation experiments. 相似文献
4.
Successful treatment of chronic idiopathic urticaria and angioedema with cimetidine alone 总被引:1,自引:0,他引:1
Jafar Farnam M.D. J. Andrew Grant M.D. Brock G. Guernsey Pharm. D. Joseph L. Jorizzo M.D. Emil R. Petrusa Ph. D. 《The Journal of allergy and clinical immunology》1984,73(6):842-845
We have studied a 50-year-old white man with chronic urticaria and angioedema who has responded to treatment with cimetidine alone for over 2 yr. In a double-blind, placebo-controlled study, cimetidine alone was at least as effective as chlorpheniramine in relief of urticaria and angioedema. Additionally, cimetidine significantly inhibited (p less than 0.01) the wheal response to histamine when it was compared to placebo. The inhibition of wheal response to histamine by cimetidine was significantly higher (p less than 0.05) than chlorpheniramine. The presence of predominantly H2- rather than H1-histamine receptors in the cutaneous blood vessels may be responsible for the therapeutic effects of cimetidine in this patient. 相似文献
5.
Prakash N. Rao PhDa f Xin Cai MDa f Raman Venkataramanan PhDb Jeffrey L. Platt MDd Anthony Demetris MDa c Allen Thunberg MDe Connie Faltynek PhDe Thomas Starzl MD PhDa Prem Kumar MDf 《The Journal of allergy and clinical immunology》1995,95(6)
Reperfusion after ischemia results in endothelial cell injury and Kupffer cell activation. Inflammatory cytokines thus released can induce major histocompatibility complex antigens and increase the immunogenecity of the graft. An orthotopic rat liver allotransplant model was used to test the hypothesis that prevention of reperfusion injury by infusion of polyethylene glycol superoxide dismutase (PEG-SOD) would result in long-term allograft survival in the presence of subthreshold immunosuppressive dosages. ACI rats were used as donors, and Lewis strain rats as recipients. Orthotopic liver transplantation was initially performed to identify a subthreshold dose of the immunosuppressant FK-506, which would be unable to extend survival longer than control untreated rats with this strain combination. After testing three intramuscular FK-506 doses of 0.04, 0.08, and 0.16 mg/kg, it was observed that an FK-506 dose of 0.04 mg/kg/day for 14 days was unable to extend survival longer than in untreated recipients. This dose of FK-506 was used in combination with PEG-SOD at doses of 1000, 3000, 10,000, or 30,000 units. Recipient animals were treated intravenously with PEG-SOD as a loading dose to facilitate tissue penetration on day 1, and beginning on the day of transplantation, every 2 days for the duration of the study. Results of histologic studies and mean survival time were compared in untreated recipients and in rats treated with PEG-SOD plus 0.04 mg/kg/day FK-506. Mean survival time was increased significantly in these animals (p < 0.007) to 40.6 ± 25.6 days as compared with either untreated rats (10.0 ± 2.7 days) or rats treated with 0.04 mg/kg FK-506 alone (13.7 ± 4.2 days). Histologic examination demonstrated a significant reduction in the cellular infiltrate in rats treated with PEG-SOD plus FK-506, as compared with recipients treated with either agent alone or left untreated. Our results therefore suggest a potential approach to reducing immunosuppression in transplantation. (J ALLERGY CLIN IMMUNOL 1995;95:1276-81.) 相似文献
6.
Liane A. Arcinas Weiang Yan Davinder S. Jassal Michael P. Love Michael H. Yamashita Basem Elbarouni 《The Canadian journal of cardiology》2018,34(12):1688.e5-1688.e7
We describe a case of a 54-year-old woman who had a right cardiac mass found on coronary angiography. Echocardiography, computed tomography, and cardiac magnetic resonance imaging characterized it as a thrombosed giant right coronary artery aneurysm. This was confirmed on pathology. We present the role of multimodality cardiovascular imaging in the diagnosis and characterization of a giant coronary artery aneurysm. 相似文献
7.
8.
目的研究生长激素释放激素受体激动剂MR409对基因缺陷小鼠Db/Db糖尿病小鼠(Db/Db小鼠)血管钙化(VC)的保护作用。方法以12周龄雄性野生型(WT)C57BL/6小鼠为WT组(对照组),12周龄雄性Db/Db小鼠随机分为Db/Db组(糖尿病组)和MR409组(MR409治疗组)。MR409组隔天给予MR409(15μg/次)治疗8周。第8周末,检测小鼠血清碱性磷酸酶(ALP)和血糖水平。HE染色观察小鼠主动脉形态变化。von Kossa染色、茜素红染色检测主动脉钙盐沉积。离体血管灌流系统测定内皮依赖性血管舒张功能。免疫组织化学染色检测主动脉钙化相关蛋白Runt相关转录因子2(Runx2)蛋白表达。二氢乙锭荧光染色检测主动脉活性氧(ROS)水平。结果与WT组比较,Db/Db组血清ALP活性升高,血管壁厚度增加,血管舒张功能降低,主动脉ROS水平增加(P0.05);与Db/Db组比较,MR409组ALP活性降低,主动脉肥厚减轻,血管舒张功能改善,主动脉ROS水平降低(P0.05)。与WT组比较,Db/Db组有明显的VC,表现为主动脉钙盐沉积增加,Runx2蛋白表达升高(P0.05);与Db/Db组比较,MR409组主动脉钙盐沉积减轻,Runx2蛋白表达降低(P0.05)。结论 MR409能显著抑制糖尿病小鼠VC,减轻主动脉增厚,改善血管内皮功能,其机制可能与抑制氧化应激诱导的Runx2表达升高有关。 相似文献
9.
Patel Preeti; Pal Suvankar; Ashley Caroline; Sweny Paul; Burns Aine 《Nephrology, dialysis, transplantation》2005,20(5):985-987
10.